MARKET
IPO

PBLS

Parabilis Medicines Inc.
PBLS
NASDAQ
Upcoming IPOs
Expected Listing Date: 2026-06-10
P/E
P/S
P/B
MARKET CAP
INDUSTRY
-
-
-
1.85B~2.07B
-
2026-05-19
Public Filing
View Prospectus
Pending
Offering
Price Range: 17.00~19.00
Shares to be Issued: 25.00M
2026-06-09
Offering End Date
Offering Price: Pending
Post IPO Outstanding: 108.84M
2026-06-10
Listed
No Data
About PBLS
Parabilis Medicines Inc, formerly known as Fog Pharmaceuticals Inc, is a United States-based company. The Company operates as a clinical-stage biopharmaceutical company. It is focused on discovering and developing transformative medicines that target disease-driving proteins historically considered “undruggable.” It leverages its Helicon platform, which consists of engineered, stabilized, cell‑penetrant helical peptides designed to bind and modulate intracellular protein targets with high specificity and affinity. Its pipeline primarily focuses on oncology, with programs such as zolucatetide being evaluated in clinical trials for solid tumors.

Webull offers Parabilis Medicines Inc. stock information, including NASDAQ: PBLS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PBLS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PBLS stock methods without spending real money on the virtual paper trading platform.